News
Public · Published
'Dean Of Valuation' Aswath Damodaran Trims His Anthropic IPO View, Flags 'Fragility' Of $1-Trillion Revenue Target
Aswath Damodaran lowered his estimated value for Anthropic to $1.45 trillion from $1.475 trillion after the company updated its S-1 filing with third-quarter earnings figures. He said the update did not materially change his thesis or his projection of $100 billion in revenue over the coming 12 months. The headline also flags a $1-trillion revenue target.
Published:
Updated:
What happened
Aswath Damodaran lowered his estimated value for Anthropic to $1.45 trillion from $1.475 trillion after the company updated its S-1 filing with third-quarter earnings figures. He said the update did not materially change his thesis or his projection of $100 billion in revenue over the coming 12 months. The headline also flags a $1-trillion revenue target.
Confirmed
Global impact / market context
Damodaran says his valuation depends heavily on Anthropic reaching $1 trillion in revenue within ten years, an assumption he calls fragile. If revenue falls short, the company could face operational problems, while businesses that depend on its revenue could also be affected.
Analyst inference
The article describes a valuation shaped more by long-term revenue expectations than by one quarter’s results. To support those expectations, Anthropic would need to lead the premium AI market, maintain strong pricing power, and build AI agents customers keep using, while preserving software-style operating margins.
Analyst inference
What to watch
- Watch whether Anthropic’s next reported results support Damodaran’s $100 billion revenue projection for the coming 12 months; he said the latest quarterly figures did not materially change it. Analyst inference
- Track signs that Anthropic can charge premium prices and keep customers using its AI agents, the conditions Damodaran says are needed to sustain software-style operating margins. Analyst inference
- Watch whether Anthropic updates its ten-year revenue target or its S-1 figures; a change could alter the assumptions behind Damodaran’s valuation, though no such update is reported here. Analyst inference
Affected assets
- XRP — XRP